STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- Calliditas
Therapeutics AB (Nasdaq: CALT)(Nasdaq Stockholm: CALTX)
("Calliditas") today announced that management will present at and
participate in the following conferences:
- The Jefferies London Healthcare Conference, November 14-16 2023, in London, UK. CEO Renee
Aguiar-Lucander will present at 2pm
GMT on Wednesday 15 November.
- The Stifel Healthcare Conference 2023, November 15 2023, in New York, USA.
President of North America,
Andrew Udell, will take part in a fireside chat at
10:10am ET on Wednesday 15
November.
- The SEB Healthcare Seminar, November
21 2023, in Stockholm,
Sweden.
- The Piper Sandler 35th Annual Healthcare Conference,
November 28-30 2023 in New York, NY, USA.
CEO Renée Aguiar-Lucander will also be speaking on a panel on
Day 2 of the FT Global Pharma & Biotech Summit, which is taking
place in November 7 - 9 2023 in
London, UK. The Panel `Exploring
Options for Strategic Partnerships' will take place at 11:05am GMT on Wednesday 8 November.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact persons set out above, on November 7, 2023, at 16:00
p.m. CET.
The following files are available for download:
https://mb.cision.com/Main/16574/3871004/2413261.pdf
|
Conferences Press
Release ENG
|
View original
content:https://www.prnewswire.co.uk/news-releases/calliditas-to-present-at-upcoming-investor-conferences-301980254.html